|
⚲
|
| Specialized Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001428882 |
| Sale | 2009-01-23 ($1.7 M Offered, $0.8 M Sold) |
| Fund | |
| Phone | 4129313131 |
| Address | 4900 Perry Highway Pittsburgh, 15229 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Michael Huffer | |
| Michael McMahan | |
| Daniel Sassano | |
| Francois Bitz | |
| David Robb | |
| James Smith | |
| Charles Schellhorn |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
HG Vora Opportunistic Capital Fund (Cayman) III A LP
✚
|
0.0 | |
|
HI-0804 Fund I, a series of AX-LonEal-Funds, LP
✚
|
0.0 | |
|
Hibiscus Health Sep 2024 a Series of CGF2021 LLC
✚
|
0.0 | |
|
Hibner William G. Jr.
✚
|
0.0 | |
|
Linebarger Norman Thomas
✚
|
0.0 | |
|
Hicap Uptown Square LLC
✚
|
0.0 | |
|
Hickert-Hill Diana
✚
|
0.0 | |
|
Hickey James Timothy
✚
|
0.0 | |
|
Hickey Michael A
✚
|
0.0 | |
|
HG Twin Peaks L.P.
✚
|
0.0 |